Shijiazhuang, China Clinical Trials

A listing of Shijiazhuang, China clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 112 clinical trials
Nab-paclitaxel Plus Carboplatin Versus Nab-paclitaxel Plus Capecitabine in the Treatment of Advanced Triple-negative Breast Cancer

This is a multi-center , open-lable clinical trial. Triple-negative breast cancer (TNBC) is a term applied to breast cancer cases that have <1% expression of the estrogen receptor (ER) and the progesterone receptor (PR) and do not over express HER2. TNBC is diagnosed in 15-20% of breast cancer cases and …

progesterone
triple negative breast cancer
neutrophil count
HER2
estrogen receptor
The Fourth Hospital of Hebei Medical University
 (0.7 away) Contact site
  • 0 views
  • 17 Feb, 2022
  • 1 location
A Phase I/II Clinical Study of SAF-189s in Non-small Cell Lung Cancer (NSCLC) Patients

The study comprises two phases: phase I dose escalation (including PK run-in period and treatment period) and phase II study.

kinase inhibitor
ROS1
lung cancer
neutrophil count
alopecia
Affiliated Hospital of Hebei university
 (76.8 away) Contact site
  • 0 views
  • 24 Feb, 2022
  • +39 other locations
Perioperative Treatment of Combined SOX With Apatinib and Camrelizumab for Oesophagogastric Cancer

The study is being conducted to evaluate the efficacy, safety and tolerability of chemotherapy and apatinib with or without camrelizumab in the neoadjuvant (prior to surgery) or adjuvant (after surgery) treatment of previously untreated adults with gastric and gastroesophageal junction (GEJ) adenocarcinoma.

Affiliated Hospital of Hebei university
 (76.8 away) Contact site
  • 0 views
  • 23 Feb, 2022
  • +22 other locations
Three Drugs in Advanced Gastric Cancer Neoadjuvant Chemotherapy for Stage Ⅲ Clinical Study

The purpose of this study is to assess the relationship of pCR rate and efficacy by comparing the two drugs and three drugs as neoadjuvant chemotherapy in advanced gastric cancer patients.

adenocarcinoma
neutrophil count
docetaxel
gastric adenocarcinoma
oxaliplatin
Fourth Affiliated Hospital of Hebei Medical University
 (0.7 away) Contact site
  • 88 views
  • 22 Jan, 2022
  • 1 location
Sympathetic Mapping/ Ablation of Renal Nerves Trial (SMART)

To evaluate the safety and efficacy of targeted renal sympathetic denervation using SyMapCath I in patients with pharmacotherapy and uncontrolled hypertension for at least 6 months, then after standardized antihypertensive drug therapy (at least two drugs) for at least 28 days, office systolic blood pressure (BP) is still 150mmHg, 180mmHg.

hypertension
uncontrolled hypertension
beta blockers
essential hypertension
antihypertensive drugs
Norman Bethune International Peace Hospital
 (1.3 away) Contact site
  • 0 views
  • 26 Jan, 2022
  • +12 other locations
Study to Evaluate Efficacy and Safety of Oral Abexinostat in Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL)

An open-label, single-arm, multi-center phase 2 study to evaluate the efficacy and safety of abexinostat, as monotherapy in patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL)

The Forth Hospital of Hebei Medical University
 (0.7 away) Contact site
  • 1 views
  • 04 Mar, 2022
  • +22 other locations
A Study of TQ-B3525 in the Treatment of Relapsed / Refractory Follicular Lymphoma (FL)

The objective of this study is to evaluate the efficacy of TQ-B3525 in patients with relapsed / refractory follicular lymphoma.

Shanxi Provincial Cancer Hospital
 (107.3 away) Contact site
  • 0 views
  • 24 Jan, 2021
  • +30 other locations
4SCAR-T Therapy Post CD19-targeted Immunotherapy

This study will evaluate safety and efficacy of a combination of 4th generation chimeric antigen receptor gene-modified T cells (4SCAR-T) targeting CD19-negative B-ALL that express alternative surface antigens such as CD22, CD10, CD20, CD38, and CD123, as many patients relapse after anti-CD19 immunotherapy. Clinical response and optiminzation of a standardized …

The Seventh Affilliated Hospital, Sun Yat-Sen University
 (1052.2 away) Contact site
  • 0 views
  • 24 Jan, 2021
  • +2 other locations
A Study to Evaluate the Safety and Tolerability Pharmacokinetics Pharmacodynamics and Preliminary Efficacy of TJ011133 as Monotherapy and in Combination With Azacitidine (AZA) in Patients With Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)

This study is a phase I/II study of TJ011133 as Monotherapy and in Combination with Azacitidine (AZA) in Patients with Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS). This study include Phase I and Phase IIa study. Phase I study ClinicalTrials.gov ID is NCT04202003 and this is for phase IIa …

hydroxyurea
blast cells
leukemia
myeloid leukemia
leukapheresis
Tianjin Medical University General Hospital
 (161.7 away) Contact site
  • 5 views
  • 11 Aug, 2021
  • +26 other locations
Anti-PD-L1 Armored Anti-CD22 CAR-T/CAR-TILs Targeting Patients With Solid Tumors

This is an open-labeled, single-armed and prospective study, patients with advanced malignant solid tumors will be given with SL22P autologous CAR - T/CAR-TILs cells. The aim of the study is to evaluate the safety and efficacy of SL22P CAR-T cells, including the adverse reaction, pharmacokinetics, and the outcomes of patients.

aptt
neutrophil count
brain metastases
platelet count
metastasis
Fourth Hospital of Hebei Medical University
 (1.3 away) Contact site
  • 10 views
  • 02 Jun, 2021
  • 1 location